Traveling Across Time Zones With Type 1 Diabetes: A Pilot Study Comparing Insulin Degludec With Insulin Glargine U100.

Objective: For people with type 1 diabetes, there are limited evidence-based resources to support self-management when traveling across multiple time zones. Here, we compared glycemic control on insulin degludec versus glargine U100 as the basal insulin for adults using multiple daily injections (MDI) while traveling across multiple time zones.

Research Design And Methods: This randomized crossover pilot study compared insulin degludec versus glargine U100 for adults with type 1 diabetes using MDI insulin during long-haul travel to and from Hawaii to New York.

Real-World Association of Insurance Status with Cardio-metabolic Risk for Hispanic/Latino Adults Living on the Central Coast of California.

The primary aim of this study was to evaluate cardio-metabolic burden by insurance status for Hispanic/Latino adults in Santa Barbara, CA. HbA1c, body mass index (BMI), and health insurance status were evaluated via community-based screenings. Cardiovascular (CV) risk was assessed using the Framingham Heart Study calculator and compared with a National Health and Nutrition Examination Survey background population.